Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1892 1
1900 2
1905 1
1910 1
1922 1
1927 1
1932 1
1934 2
1936 1
1943 1
1944 1
1945 1
1947 1
1948 2
1954 1
1955 2
1956 1
1957 1
1958 4
1960 2
1962 1
1963 1
1965 3
1966 2
1967 5
1968 1
1969 1
1970 4
1971 3
1972 4
1973 6
1974 8
1976 5
1977 3
1978 3
1979 2
1980 2
1981 2
1982 1
1983 4
1984 3
1985 4
1986 3
1987 8
1988 10
1989 9
1990 10
1991 9
1992 6
1993 7
1994 16
1995 11
1996 19
1997 7
1998 13
1999 8
2000 4
2001 6
2002 12
2003 9
2004 18
2005 11
2006 15
2007 17
2008 11
2009 21
2010 16
2011 27
2012 23
2013 18
2014 29
2015 27
2016 24
2017 25
2018 36
2019 53
2020 40
2021 56
2022 37
2023 5
Text availability
Article attribute
Article type
Publication date

Search Results

722 results
Results by year
Filters applied: . Clear all
Page 1
Network pharmacology.
Hopkins AL. Hopkins AL. Nat Biotechnol. 2007 Oct;25(10):1110-1. doi: 10.1038/nbt1007-1110. Nat Biotechnol. 2007. PMID: 17921993 No abstract available.
Tumor Mutational Burden and Response Rate to PD-1 Inhibition.
Yarchoan M, Hopkins A, Jaffee EM. Yarchoan M, et al. Among authors: hopkins a. N Engl J Med. 2017 Dec 21;377(25):2500-2501. doi: 10.1056/NEJMc1713444. N Engl J Med. 2017. PMID: 29262275 Free PMC article. No abstract available.
How many drug targets are there?
Overington JP, Al-Lazikani B, Hopkins AL. Overington JP, et al. Among authors: hopkins al. Nat Rev Drug Discov. 2006 Dec;5(12):993-6. doi: 10.1038/nrd2199. Nat Rev Drug Discov. 2006. PMID: 17139284 Review.
The druggable genome.
Hopkins AL, Groom CR. Hopkins AL, et al. Nat Rev Drug Discov. 2002 Sep;1(9):727-30. doi: 10.1038/nrd892. Nat Rev Drug Discov. 2002. PMID: 12209152 Review.
Quantifying the chemical beauty of drugs.
Bickerton GR, Paolini GV, Besnard J, Muresan S, Hopkins AL. Bickerton GR, et al. Among authors: hopkins al. Nat Chem. 2012 Jan 24;4(2):90-8. doi: 10.1038/nchem.1243. Nat Chem. 2012. PMID: 22270643 Free PMC article.
The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma.
Vo JN, Wu YM, Mishler J, Hall S, Mannan R, Wang L, Ning Y, Zhou J, Hopkins AC, Estill JC, Chan WKB, Yesil J, Cao X, Rao A, Tsodikov A, Talpaz M, Cole CE, Ye JC; Multiple Myeloma Research Consortium; Bergsagel PL, Auclair D, Cho HJ, Robinson DR, Chinnaiyan AM. Vo JN, et al. Among authors: hopkins ac. Nat Commun. 2022 Jun 29;13(1):3750. doi: 10.1038/s41467-022-31430-0. Nat Commun. 2022. PMID: 35768438 Free PMC article.
722 results